Suggested Reading

Albert, L. J., and Inman, R. D. (1999). Molecular mimicry and autoimmunity. N. Engl. J. Med. 341, 2068-2074.

Cohen, I. R. (2000). Tending Adam's Garden: Evolving the Cognitive Immune Self. Academic Press, San Diego.

Critchfield, J. M., Racke, M. K., Zuniga-Pflucker, J. C., Cannella, B., Raine, C. S., Goverman, J., and Lenardo, M. J. (1994). T cell deletion in high antigen dose therapy of autoimmune encepha-lomyelitis. Science 263, 1139-1143.

Evavold, B. D., Sloan, L. J., and Allen, P. M. (1993). Tickling the TCR: Selective T-cell functions stimulated by altered peptide ligands. Immunol. Today 14, 602-609.

Gijbels, K., Galardy, R. E., and Steinman, L. (1994). Reversal of experimental autoimmune encephalomyelitis with a hydroxa-mate inhibitor of matrix metalloproteases. J. Clin. Invest. 94, 2177-2182.

Kuchroo, V. K., Das, M. P., Brown, J. A., Ranger, A. M., Zamvil, S. S., Sobel, R. A., Weiner, H. L., Nabavi, N., and Glimcher, L. H. (1995). B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 80, 707-718.

Lobell, A., Weissert, R., Storch, M. K., Svanholm, C., de Graaf, K. L., Lassmann, H., Andersson, R., Olsson, T., and Wigzell, H. (1998). Vaccination with DNA encoding an immunodominant myelin basic protein peptide targeted to Fc of immunoglobulin G suppresses experimental autoimmune encephalomyelitis. J. Exp. Med. 187, 1543-1548.

Pisetsky, D. S. (2000). Tumor necrosis factor blockers in rheumatoid arthritis. N.Engl. J. Med. 342, 810-811.

Racadot, E., Rumbach, L., Bataillard, M., Galmiche, J., Henlin, J. L., Truttmann, M., Herve, P., andWijdenes, J. (1993). Treatment of multiple sclerosis with anti-CD4 monoclonal antibody. A preliminary report on B-F5 in 21 patients. J. Autoimmunity 6, 771-786.

Scaravilli, F., An, S. F., Groves, M., and Thom, M. (1999). The neuropathology of paraneoplastic syndromes. Brain Pathol. 9, 251-260.

Sette, A., Alexander, J., Ruppert, J., Snoke, K., Franco, A., Ishioka, G., and Grey, H. M. (1994). Antigen analogs/MHC complexes as specific T cell receptor antagonists. Annu. Rev. Immunol. 12, 413-431.

Van Parijs, L., and Abbas, A. K. (1998). Homeostasis and self-tolerance in the immune system: Turning lymphocytes off. Science 280, 243-248.

Waisman, A., Ruiz, P. J., Hirschberg, D. L., Gelman, A., Oksenberg, J. R., Brocke, S., Mor, F., Cohen, I. R., and Steinman, L. (1996). Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat. Med. 2, 899-905.

Weiner, H. L., Friedman, A., Miller, A., Khoury, S. J., al-Sabbagh, A., Santos, L., Sayegh, M., Nussenblatt, R. B., Trentham, D. E., and Hafler, D. A. (1994). Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12, 809-837.

Zhang, J., and Raus, J. (1995). Clonal depletion of human myelin basic protein-reactive T-cells by T-cell vaccination. Ann. N. Y. Acad. Sci. 756, 323-326.

Was this article helpful?

0 0


Thank you for deciding to learn more about the disorder, Osteoarthritis. Inside these pages, you will learn what it is, who is most at risk for developing it, what causes it, and some treatment plans to help those that do have it feel better. While there is no definitive “cure” for Osteoarthritis, there are ways in which individuals can improve their quality of life and change the discomfort level to one that can be tolerated on a daily basis.

Get My Free Ebook

Post a comment